DE60325541D1 - Verfahren/Präparat zur Erkennung von Pankreaskrebs - Google Patents

Verfahren/Präparat zur Erkennung von Pankreaskrebs

Info

Publication number
DE60325541D1
DE60325541D1 DE60325541T DE60325541T DE60325541D1 DE 60325541 D1 DE60325541 D1 DE 60325541D1 DE 60325541 T DE60325541 T DE 60325541T DE 60325541 T DE60325541 T DE 60325541T DE 60325541 D1 DE60325541 D1 DE 60325541D1
Authority
DE
Germany
Prior art keywords
polypeptide
nucleic acid
ukw
sample
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60325541T
Other languages
English (en)
Inventor
Malte Buchholz
Thomas Gress
Stephanie Loesch
Ulrich Weidle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of DE60325541D1 publication Critical patent/DE60325541D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57438—Specifically defined cancers of liver, pancreas or kidney
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60325541T 2002-10-31 2003-10-29 Verfahren/Präparat zur Erkennung von Pankreaskrebs Expired - Lifetime DE60325541D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02024539 2002-10-31

Publications (1)

Publication Number Publication Date
DE60325541D1 true DE60325541D1 (de) 2009-02-12

Family

ID=32405681

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60325541T Expired - Lifetime DE60325541D1 (de) 2002-10-31 2003-10-29 Verfahren/Präparat zur Erkennung von Pankreaskrebs

Country Status (6)

Country Link
US (2) US7429452B2 (de)
EP (1) EP1416279B1 (de)
JP (2) JP4394924B2 (de)
AT (1) ATE419533T1 (de)
DE (1) DE60325541D1 (de)
ES (1) ES2318079T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006038904A2 (en) * 2004-08-06 2006-04-13 Applera Corporation Method and compositions for treating diseases targeting e-cadherin
WO2006022690A1 (en) * 2004-08-06 2006-03-02 Applera Corporation Method and compositions for treating diseases targeting cd71
US11001881B2 (en) 2006-08-24 2021-05-11 California Institute Of Technology Methods for detecting analytes
US11525156B2 (en) 2006-07-28 2022-12-13 California Institute Of Technology Multiplex Q-PCR arrays
US8048626B2 (en) * 2006-07-28 2011-11-01 California Institute Of Technology Multiplex Q-PCR arrays
US11560588B2 (en) 2006-08-24 2023-01-24 California Institute Of Technology Multiplex Q-PCR arrays
WO2008117067A2 (en) 2007-03-27 2008-10-02 Carl Arne Krister Borrebaeck Protein signature/markers for the detection of adenocarcinoma
US8538733B2 (en) 2008-01-25 2013-09-17 Life Technologies Corporation Methods for the analysis of dissociation melt curve data
US9708647B2 (en) 2015-03-23 2017-07-18 Insilixa, Inc. Multiplexed analysis of nucleic acid hybridization thermodynamics using integrated arrays
US9499861B1 (en) 2015-09-10 2016-11-22 Insilixa, Inc. Methods and systems for multiplex quantitative nucleic acid amplification
WO2017155858A1 (en) 2016-03-07 2017-09-14 Insilixa, Inc. Nucleic acid sequence identification using solid-phase cyclic single base extension
GB201608192D0 (en) * 2016-05-10 2016-06-22 Immunovia Ab Method, array and use thereof
JP2022525322A (ja) 2019-03-14 2022-05-12 インシリクサ， インコーポレイテッド 時間ゲート蛍光ベースの検出のための方法およびシステム
GB202010970D0 (en) 2020-07-16 2020-09-02 Immunovia Ab Methods, arrays and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US81659A (en) * 1868-09-01 m ax i mi
CA1339709C (en) * 1987-02-19 1998-03-10 Scripps Clinic And Research Foundation Monoclonal antibodies to human pancreatic cancer
WO2002008288A2 (en) * 2000-07-20 2002-01-31 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
US5912143A (en) * 1996-12-27 1999-06-15 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a human mage protein homolog
AU3395900A (en) 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides

Also Published As

Publication number Publication date
EP1416279A1 (de) 2004-05-06
ATE419533T1 (de) 2009-01-15
JP4394924B2 (ja) 2010-01-06
US20040110219A1 (en) 2004-06-10
JP2009284907A (ja) 2009-12-10
US20090136939A1 (en) 2009-05-28
US7429452B2 (en) 2008-09-30
EP1416279B1 (de) 2008-12-31
ES2318079T3 (es) 2009-05-01
JP2004147656A (ja) 2004-05-27

Similar Documents

Publication Publication Date Title
EP2890815B1 (de) Verfahren zur diagnose und behandlung von krebs
KR20210045953A (ko) 암의 평가 및/또는 치료를 위한 무 세포 dna
US20160168649A1 (en) Gene expression predictors of cancer prognosis
RU2008108907A (ru) Способ предсказания ответа на лечение
WO2012094744A1 (en) Prognostic signature for oral squamous cell carcinoma
US11312999B2 (en) Set of genes for molecular classifying of medulloblastoma and use thereof
Dolan et al. Comparison of immunohistochemical and fluorescence in situ hybridization assessment of HER-2 status in routine practice
DE60325541D1 (de) Verfahren/Präparat zur Erkennung von Pankreaskrebs
WO2018233511A1 (zh) 预测食管癌对抗erbb3抗体治疗的应答的方法和试剂盒
JP2006523456A (ja) 分子細胞遺伝学的方法を用いる癌連鎖遺伝子および治療標的の確認
US8747867B2 (en) Cancer markers
EP3954784A1 (de) Zusammensetzung zur diagnose oder prognose der vorhersage von gliomen sowie verfahren zur bereitstellung von informationen in zusammenhang damit
KR102562614B1 (ko) 비침습적 방법을 이용한 치주 질환 진단용 키트
WO2007053659A2 (en) Method of screening for hepatocellular carcinoma
KR20170127774A (ko) 유전자의 결실을 이용한 유방암 환자의 예후 예측 방법
CN112813167B (zh) 标志物linc01977及其应用
KR102085663B1 (ko) Wrb 유전자의 메틸화 수준을 이용한 소혈관폐색증의 예측 또는 진단을 위한 정보제공방법 및 이를 위한 조성물
KR102085667B1 (ko) Gpr160 유전자의 메틸화 수준을 이용한 소혈관폐색증의 예측 또는 진단을 위한 정보제공방법 및 이를 위한 조성물
KR20170106084A (ko) 사이클린(Cyclin) D1 b 를 이용한 갑상선암의 진단 방법
KR101238196B1 (ko) 대장암의 간 전이 진단용 조성물 및 그 용도
KR101370108B1 (ko) 위암 진단용 마커로서 ｈｄａｃ2의 용도
EP4317458A1 (de) Follikularer schilddrüsenkrebsspezifischer marker
JP5055543B2 (ja) 新規癌検出方法、癌検出器具、および癌検出キット
JP2023162781A (ja) 診断薬、薬効予測キット、薬効予測方法、及びマーカー
KR20210021279A (ko) 고혈압 또는 비만의 예측 또는 진단용 조성물

Legal Events

Date Code Title Description
8364 No opposition during term of opposition